Preclinical development of EO1001, a novel irreversible brain penetrating pan-ErbB inhibitor (Oral Presentation)

Wang Shen, Jeffrey Bacha, Sarath Kanekal, Neil Sankar, Wang ZhenZhong, Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, Andrew T. Parsa, Jeffrey J. Raizer, Shi-Yuan Cheng, Alexander H. Stegh, Andrew P. Mazar, Francis J. Giles, Harry D. Pedersen, Jann N. Sarkaria, Nicholas Butowski, Theodore Nicolaides, C. David James, and Dennis Brown

Society for NeuroOncology Inaugural Conference on Brain Metastases.  August 2019,  New York, USA